<DOC>
	<DOCNO>NCT01757444</DOCNO>
	<brief_summary>In 2012 , announce availability new ventilator ( BiPAP- A40 ) , could offer potential advantage fix level pressure support , particular , patient obesity hypoventilation syndrome ( OHS ) . One key benefit BiPAP A40 innovative ventilation mode call AVAPS-AE , automatically maintain airway patency deliver correct level ventilation user require , whatever body position sleep stage . AVAPS-AE mode also aim help clinician initial titration therapy , provide long term comfort assure therapy compliance . However , study physiologic clinical effect yet perform . The aim singled-blind randomise multicentre control trial prospectively investigate effect BiPAP spontaneous/timed ( S/T ) AVAPS-AE ventilation mode 8 week sleep quality , ventilation pattern , gas exchange , symptom , body composition , level physical activity health-related quality life OHS patient .</brief_summary>
	<brief_title>Non Invasive Ventilation : Efficacy New Ventilatory Mode Patients With OHS</brief_title>
	<detailed_description>Efficacy sleep quality , symptom , physical activity quality life</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Obesity</mesh_term>
	<mesh_term>Hypoventilation</mesh_term>
	<mesh_term>Obesity Hypoventilation Syndrome</mesh_term>
	<criteria>Man woman , stable patient obesity hypoventilation syndrome , naives non invasive ventilation . PaCO2 ≥ 45 mmHg . PaO2 &lt; 70 mmHg BMI ≥ 30Kg . m2 Chronic obstructive pulmonary disease Neuromuscular disease Scoliosis Cardiac insufficiency Significant psychiatric disease Sleep apnea syndrome central apnea index &gt; 10 % Treatment benzodiazepines inclusion</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>July 2015</verification_date>
</DOC>